カテゴリ： MarketLine, アメリカ, 企業調査

PAREXEL International Corporation：企業の戦略・SWOT・財務情報

◆英語タイトル：PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C8762
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：54
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

PAREXEL International Corporation – Strategy, SWOT and Corporate Finance Report
Summary

PAREXEL International Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PAREXEL International Corporation (PAREXEL or ‘the company’) is a leading global biopharmaceutical services provider. The company’s product and service offerings include Clinical trials management, Biostatistical analysis, Pharmacovigilance, Clinical pharmacology, Regulatory information management (RIM) solutions, ClinPhone Randomization and trial supply management services (RTSM), Electronic data capture systems (EDC), Clinical trial management systems (CTMS), Regulatory information management (RIM) solutions, ClinPhone Randomization and trial supply management services (RTSM), Electronic data capture systems (EDC) and Clinical trial management systems (CTMS), among others. PAREXEL operates in the Americas, Europe, Asia Pacific, the Middle East and Africa. The company is headquartered in Waltham, Massachusetts, the US.

Scope

- Detailed information on PAREXEL International Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PAREXEL International Corporation in the form of a SWOT analysis
- An in-depth view of the business model of PAREXEL International Corporation including a breakdown and examination of key business segments
- Intelligence on PAREXEL International Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PAREXEL International Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PAREXEL International Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PAREXEL International Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PAREXEL International Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
PAREXEL International Corporation: Company Overview 9
PAREXEL International Corporation: Overview and Key Facts 9
PAREXEL International Corporation: Overview 9
PAREXEL International Corporation: Key Facts 9
PAREXEL International Corporation: Key Employees 10
PAREXEL International Corporation: Key Employee Biographies 12
PAREXEL International Corporation: Major Products and Services 19
PAREXEL International Corporation: Company History 20
PAREXEL International Corporation: Management Statement 25
PAREXEL International Corporation: Locations and Subsidiaries 29
PAREXEL International Corporation: Key Competitors 30
PAREXEL International Corporation: Company Analysis 31
PAREXEL International Corporation: Business Description 31
PAREXEL International Corporation: SWOT Analysis 32
PAREXEL International Corporation: SWOT Overview 32
PAREXEL International Corporation: Strengths 32
PAREXEL International Corporation: Weaknesses 33
PAREXEL International Corporation: Opportunities 33
PAREXEL International Corporation: Threats 34
PAREXEL International Corporation: Corporate Financial Deals Activity 36
PAREXEL International Corporation: Financial Deals Overview 36
PAREXEL International Corporation: Targets and Partners 37
PAREXEL International Corporation: Top Deals 2014 – 2018YTD* 38
PAREXEL International Corporation: Advisors 39
PAREXEL International Corporation: Top Legal Advisors 39
PAREXEL International Corporation: Top Financial Advisors 39
PAREXEL International Corporation: Mergers and Acquisitions 40
PAREXEL International Corporation: Partnership 41
PAREXEL International Corporation: Private Equity and Ownership 42
PAREXEL International Corporation: Recent Developments 43
PAREXEL International Corporation: News and Events Summary 43
PAREXEL International Corporation: Business Expansion 47
PAREXEL International Corporation: Contracts 48
PAREXEL International Corporation: Corporate Governance 49
PAREXEL International Corporation: Financial Deals 49
PAREXEL International Corporation: Financial Performance 50
PAREXEL International Corporation: Market Developments 50
Appendix 52
Contact Us 52
Methodology 52
About MarketLine 53

List of Tables
Table 1: PAREXEL International Corporation: Key Facts
Table 2: PAREXEL International Corporation: Key Employees
Table 3: PAREXEL International Corporation: Company History
Table 4: PAREXEL International Corporation: Locations and Subsidiaries
Table 5: PAREXEL International Corporation: Key Competitors
Table 6: PAREXEL International Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: PAREXEL International Corporation: Targets and Partners
Table 8: PAREXEL International Corporation: Top Deals 2014 - 2018YTD*
Table 9: PAREXEL International Corporation: Legal Advisor Ranking by Value (US$m)
Table 10: PAREXEL International Corporation: Financial Advisor Ranking by Value (US$m)
Table 11: PAREXEL International Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: PAREXEL International Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 13: PAREXEL International Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: PAREXEL International Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: PAREXEL International Corporation: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 16: PAREXEL International Corporation: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 17: PAREXEL International Corporation: News and Events Summary
Table 18: PAREXEL International Corporation: Business Expansion
Table 19: PAREXEL International Corporation: Contracts
Table 20: PAREXEL International Corporation: Corporate Governance
Table 21: PAREXEL International Corporation: Financial Deals
Table 22: PAREXEL International Corporation: Financial Performance
Table 23: PAREXEL International Corporation: Market Developments

List of Figures
Figure 1: PAREXEL International Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: PAREXEL International Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: PAREXEL International Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: PAREXEL International Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: PAREXEL International Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 6: PAREXEL International Corporation: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: PAREXEL International Corporation: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[PAREXEL International Corporation：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Bunzl plc (BNZL)：医療機器：M&Aディール及び事業提携情報
    Summary Bunzl plc (Bunzl) is a global distribution and outsourcing company. The company offer its customers with a unique business concept, which provides individual solutions along the supply chain to a variety of businesses and numerous goods around the world. It supplies a broad range of non-food …
  • Leggett & Platt Incorporated：企業のM&A・事業提携・投資動向
    Leggett & Platt Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leggett & Platt Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Ashtead Group Plc (AHT)：企業の財務・戦略的SWOT分析
    Ashtead Group Plc (AHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pioneer Natural Resources Co (PXD)-石油・ガス分野：企業M&A・提携分析
    Summary Pioneer Natural Resources Company (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, and West Panhandle. In Permian Basin, the company carries out its exploration and production activit …
  • HCA Healthcare Inc (HCA)：企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • International Zeolite Corp：企業の戦略・SWOT・財務分析
    International Zeolite Corp - Strategy, SWOT and Corporate Finance Report Summary International Zeolite Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Biocept Inc (BIOC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Estee Lauder Companies Inc：企業の戦略・SWOT・財務情報
    Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BioChain Institute Inc：医療機器：M&Aディール及び事業提携情報
    Summary BioChain Institute Inc (BioChain) is a medical device company that designs, develops and markets diagnostic products. The company offers processed bio-sample products and analysis services used in translational medicine, companion diagnostics, and clinical product research and development. I …
  • Owens Corning (OC)：企業の財務・戦略的SWOT分析
    Owens Corning (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Global Insurance Management Limited：企業の戦略・SWOT・財務分析
    Global Insurance Management Limited - Strategy, SWOT and Corporate Finance Report Summary Global Insurance Management Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Method Products, Inc.：企業の戦略的SWOT分析
    Method Products, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • AvidBiotics Corp：製薬・医療：M&Aディール及び事業提携情報
    Summary AvidBiotics Corp (AvidBiotics) is a pharmaceutical company that develops non-antibody therapeutic proteins targeting cancer cells, virus-infected cells and pathogenic bacteria. The company develops a portfolio of therapeutic protein candidates and protein engineering platforms which include …
  • Accugenomics Inc-医療機器分野：企業M&A・提携分析
    Summary Accugenomics Inc (Accugenomics) is a provider of molecular diagnostics for cancer. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Women’s Choice Pharmaceuticals LLC-製薬・医療分野：企業M&A・提携分析
    Summary Women's Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that provides branded prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diab …
  • Fremont Michigan InsuraCorp Inc.：企業の戦略・SWOT・財務情報
    Fremont Michigan InsuraCorp Inc. - Strategy, SWOT and Corporate Finance Report Summary Fremont Michigan InsuraCorp Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Aphios Corp-製薬・医療分野：企業M&A・提携分析
    Summary Aphios Corp (Aphios) is a biotechnology company that develops nanotechnology drug delivery platforms. The company provides technology platforms and enhanced therapeutics for the treatment of infectious diseases, cancers and central nervous system disorders. Its therapeutic products include Z …
  • Phytel Inc-製薬・医療分野：企業M&A・提携分析
    Summary Phytel Inc (Phytel), a subsidiary of International Business Machines Corporation is an integrated population health management software and solutions provider. The company’s services include reduce total cost of care, prepare for value based care, increase patient engagement, measure quality …
  • VistaGen Therapeutics Inc (VTGN)：医療機器：M&Aディール及び事業提携情報
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Mylan NV (MYL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceutical products in multiple forms for various disease conditions related to respiratory and allerg …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆